info@olpharm.ru
A draft amendment to the law “On the Circulation of Medicines” has been submitted to the State Duma, which should bring Russian pharmaceutical
The developer of vaccines, the biotech company DBT (Development of Biotechnologies) of the Human Stem Cell Institute (HSCI) group, raised 155 million
MATTERHORN is a Phase III international study on the use of immunotherapy in combination with chemotherapy for gastric cancer and esophageal–gastric